• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    BPGbio Publishes Groundbreaking Solid Tumor Study With BPM31510

    GLOBENEWSWIRE

    BPGbio Names John Dvor as Executive VP, Corporate Development

    GLOBENEWSWIRE

    Bpgbio, Icahn School Of Medicine Reveal Breakthrough Brain Study

    GLOBENEWSWIRE

    BPGbio Unveils BPM31510 Phase 2 Glioblastoma Data At ESMO 2025

    GLOBENEWSWIRE

    BPGbio Welcomes Sheikh Dr. Khalid Bin Jabor Al Thani

    GLOBENEWSWIRE

    BPGbio Names Dr. Brian Berman Interim Chief Medical Officer

    GLOBENEWSWIRE

    BPGbio Sponsors MitoAction Energy Walk at Boston’s Franklin

    GLOBENEWSWIRE

    Bpgbio Appoints Nai Interrogative Biology® Co-Inventor Slava

    GLOBENEWSWIRE

    BPGbio Announces Completion of Enrollment BPM31510 Trial for GBM

    GLOBENEWSWIRE

    BPGbio to Present E2-based Protein Degradation Program in Europe

    BUSINESSWIRE

    BPGbio`s Lipidomics Unveils Lipid-Rich Cartilage In Science

    BUSINESSWIRE

    BPGbio Wins BioTech AI Company of the Year Award

    BUSINESSWIRE

    BPGbio Present Immuno-Oncology Research on BPM31510 & BRG399 at SITC

    BUSINESSWIRE

    BPGbio CEO to Present at Google Cancer AI Symposium

    BUSINESSWIRE

    BPGbio Presents BPM31510 Data at MitoCon 2024

    BUSINESSWIRE

    BPGbio Presents E2-Based Targeted Protein Degradation Approach

    BUSINESSWIRE

    BPGbio CEO Named PharmaVoice 100 Winner For AI Drug Discovery

    BUSINESSWIRE

    BPGbio And Oxford Enter Strategic Collaboration On Protein Research

    BUSINESSWIRE

    BPGbio To Present Huntington`s And Alzheimer`s Findings

    BUSINESSWIRE

    BPGbio And Joslin Publish Blue Light Fat Reduction Study

    BUSINESSWIRE

    BPGbio Presents Glioblastoma Trial Update At ESMO Congress 2024

    BUSINESSWIRE

    BPGbio To Present Mitochondrial Medicine Research At EBEC 2024

    BUSINESSWIRE

    BPGbio Announces Phase 2 BPM31510 Glioblastoma Trial-in-Progress Update

    BUSINESSWIRE

    BPGbio Wins BioTech Breakthrough Award for Therapeutics Platform of The Year

    BUSINESSWIRE

    BPGbio Announces First Patients Dosed in Phase 2 Trial of AI-Developed BPM 31510

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.